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INTRODUCTION 
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INTRODUCTION 
 
Retinopathy of Prematurity is a neovascularising disease of 
premature retina that in it’s most severe form can lead to retinal 
detachment and subsequent blindness. ROP is a multifactorial 
vasoproliferative disorder of retina, that increases in incidence with 
decreasing gestational age and birth weight. Approximately 65% of 
infants with a birth weight of <1250 gm, and 80% of infants with a birth 
weight <1000 gm, will develop some degree of ROP. In view of ongoing 
trend for resuscitation of smaller infants with  lower gestational ages 
along with increased survival of VLBW & ELBW babies, an increase in 
incidence of ROP is expected
.(1,2)
. 
 In 1942, Terry found out this disorder and termed it as “Retrolental 
fibroplasia
(3)”. Initially it was thought to be due to oxygen exposure. So 
with restricted oxygen use, the incidence of ROP came down. Then with 
improvement of neonatal intensive care facilities, more and more 
premature infants are surviving and are more prone to develop ROP
4
. The 
natural course of ROP is either it may resolve spontaneously or with laser 
therapy, or it may cause mild myopia to total blinding retinal detachment. 
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Pathogenesis of ROP 
 Beginning  at 16 weeks, retinal angiogenesis normally proceeds 
from the optic disc to periphery reaching the outer rim of the retina 
nasally at about 36 weeks and extending temporally by approximately 40 
weeks
20
. 
 Injury to this process may result in pathological changes in the 
growing retina. Initially it causes cessation of vasculogenesis followed by 
abrupt termination of vessels marked by a thin line in the retina which 
then grows into an ridge made up of mesenchymal and endothelial cells. 
Cell division and differentiation may resume later and vascularisation of 
retina may proceed. Sometimes, abnormal proliferation of vessels out of 
the plane of the retina, into the vitreous and over the surface of the retina 
may occur. Then it is followed by cicatrization and traction on the retina 
may occur and which can lead to retinal detachment.  
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HIGH FiO2/ PREMATURITY/SICK INFANT
FREE RADICAL INDUCED CELLULAR 
DAMAGE
CESSATION OF VASCULOGENESIS
PERIPHERAL HYPOXIA
RELEASE OF VEGF
ABNORMAL FIBROVASCULAR 
GROWTH
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Risk factors: 
 The Major risk factors associated with ROP are prematurity and 
associated retinal immaturity. The other contributory factors are, 
oxygenation, respiratory distress , apnea, bradycardia, heart Disease 
infection, hypercarbia, acidosis, anemia and the need for transfusion. 
Generally, the lower the gestational age, the lower the birth weight, and 
the sicker the infant are, the greater the risk is for ROP. 
Risk factors contributing to development of ROP: 
1. Lower birth weight 
2. Lesser gestational age 
3. Respiratory distress 
4. Apnea 
5. Bradycardia 
6. Heart disease 
7. Infection 
8. Oxygenation  
9. Hypercarbia 
10. Anaemia 
11. Acidosis 
12. Need for transfusion  
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              The basic pathogenesis of ROP is unclear. Probably free radical 
mediated cellular damage in newborns who are exposed to high inspired 
oxygen concentrations. Then followed by peripheral hypoxia and release 
of VEGF. in the non vascularised retina. Retinal hypoxia may be due to 
poor pulmonary function, which causes upregulation of VEGF, which 
produces abnormal fibrovascular growth in susceptible infants. This 
faulty neovascularisation may cause scarring and loss of vision. 
The following factors are believed to be protective against the 
development of ROP, though the effect is not yet proven. 
1. Antenatal steroids 
2. Vitamin E  
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Classification: 
 The phases and severity of the disease process are classified into 
five stages. 
Stage I  
Is characterized by a demarcation line separating vascularised and 
avascular retina within the retinal plane. 
Stage II  
Is characterized by a ridge, enlargement of demarcation line extending up 
and out of retinal plane  
Stage III  
Is characterized by a ridge and development of extra retinal fibrovascular 
tissue. 
Stage IV  
Is characterised by subtotal retinal detachment caused by traction from 
the proliferating tissue in the vitreous or on the retina  
Stage IVa :  Subtotal retinal detachment not involving macula 
Stage IVb:  Subtotal retinal detachment involving Macula  
Stage V  
Total Retinal Detachment 
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 ROP is classified according to ICROP
5
 (international classification 
of ROP. 
 The current classification of  ROP describes the location, extent 
and severity of the disease. Retina is divided into three concentric Zones 
around the optic disc.  
Zone I  
The posterior or the inner zone is marked upto the extent of twice as the 
disc macular distance (or) 30 degree in all directions from the optic disc. 
Zone II 
The middle zone is marked from the outer edge of zone I to the ora 
serrata nasally and to the anatomic equator temporally. 
Zone III 
The outer zone is marked by the residual crescent which extends from the 
outer border of zone II to the ora serrata temporally. 
 The extent of involvement is marked by the number of 
circumferential clock hours involved. 
Zones of Retina 
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Terminology related to ROP 
PLUS  disease: 
 A form of  ROP when the blood vessels of retina become enlarged 
and twisted, indicating a worsening of the disease. 
Threshold ROP: 
 Threshold is a level of severity of ROP at which the risk of 
blindness is predicted to approach 50%. It is marked as zone I or zone II 
with ROP stage III with PLUS disease. 
Prethreshold ROP: 
 It is less serious than threshold ROP which includes any stage of 
ROP in zone I or zone II,  
Stage 2 ROP with PLUS disease or zone II,  
Stage 3 ROP.  
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Clinical Course 
 In about 90% of at risk infants, ROP resolve spontaneously. In 
remaining 10%,  the disease progress to severe course. Some children 
with regressed ROP may present with demarcation lines, 
undervascularisation of peripheral retina, retinal pigmentary changes, 
retinal breaks. Others may develop total retinal detachment. Some may 
develop cataract, glaucoma and inflammatory signs. The end stage of 
ROP is a painful blind eye or a phthisical eye. 
Diagnosis: 
 Systematic serial ophthalmologic examinations of infants with 
birth weight <1500 gm, and infants of gestational age <34 weeks should 
be done. The initial examination should be done at 4-6 weeks of 
chronological age. Follow-up period is usually 2 weeks or less. 
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Treatment:- 
 Cryotherapy or Laser photocoagulation of avascular retina is the 
treatment of choice for ROP in infants with advanced stages. Serial 
ophthalmological examinations are required in others. Regarding 
prevention of ROP, oxygen alone is neither sufficient nor necessary to 
produce ROP and no safe level of oxygen has yet been determined. 
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REVIEW OF LITERATURE 
1. In a study, conducted by chaudhari S. et al6 Division of 
Neonatology, Department of Paediatrics, KEM Hospital, Pune, 
named “Retinopathy of prematurity in a tertiary care center – 
incidence, risk factors and outcome” revealed that the incidence of 
ROP in the 552 infants who were screened was 22.3%. No ROP 
was found in infants weighing  2000gm, or with a gestational age 
more than 36 weeks. Risk factors Predisposing ROP were 
Septicemia (P<0.001), apnea (P=0.0001) and oxygen therapy 
(P=0.031). Out of the 123 infants who had ROP, 41, (33.6%) 
needed laser photocoagulation. 22 children(53.6%) were seen at 3 
years of age, of which 10 children had myopia, 1 had amblyopia, 9 
children had completely normal outcome. They concluded that one 
third of the infants with ROP needed Laser photocoagulation, risk 
factors predisposing to ROP were septicemia, apnea, oxygen 
therapy and use of blood products. 
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2. Santhosh Mahapatra, et-al 7 had done a study named “Incidence of 
ROP at Neonatal Intensive Care Units at tertiary care centers of 
Orissa” in S.C.B. Medical College and SBVPGI of Pediatris, 
Cuttak. The study results showed that out of 656 screened infants, 
26 developed ROP. Babies with higher stages of ROP had lesser 
birth weights. In the study, the incidence of ROP was 3.96%. The 
causes for the lower incidence rate might be high infant mortality 
rate in Orissa, high fall outs, and poor health awareness among the 
people. 
3. Padmani Karna at el8 conducted a study named “Retinopathy of 
Prematurity and risk factors: a prospective cohort study” at 
Division of Neonatology, Dept. of Pediatrics & Human 
development, Michigan State University, USA. The study results 
showed that out of 576 neonates with 1500g birth weight, 7.8% 
developed severe ROP. Gestational age and duration on ventilation 
were associated with development of ROP. 
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4. May May choo et al9 conducted a study named “Retinopathy of 
Prematurity in extremely low birth weight infants in Malaysia” at 
University of Malaya Medical Centre, Kualalampur. The study 
revealed that out of 70 ELBW infants, 41 (58.6%) developed ROP 
and 23 (32.9%) required laser treatment. The risk factors for 
development of  ROP were gestational age <28 weeks (OR=1.8, 
P=0.001), duration of ventilation >1 week (OR=1.5, P=0.012) and 
intraventricular hemorrhage (Or=2.5, P=0.010) 
5. Maheshwari R et al10  conducted a study named “Incidence and risk 
factors of Retinopathy of Prematurity in a tertiary care newborn 
unit in New Delhi”. The Study showed that the incidence of ROP 
was 20% and the occurrence of ROP was inversely related to the 
gestational age and birth weight. Blood transfusion and clinical 
sepsis were the associated significant risk factors for ROP.  
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6. AHA Abdel Hakeem et al11  conducted a study named 
“Retinopathy of Prematurity: A study of incidence and risk factors 
in NICU of Al-Miniya University Hospital in Egypt”. at 
Department of pediatrics, Faculty of Medicine Al-Miniya 
University, Egypt. The study showed that out of 172 screened 
infants, 33 (19.2%) developed ROP. Of which 18 (54.5%) cases 
were in stage I, 9 (27.3%) cases in stage II, 6 (18.2%) cases in  
stage III, no cases in stage IV stage V. Among the risk factors, 
there was a significant relationship between the occurrence of ROP 
and gestational age (P=0.000), sepsis (P=0.004), oxygen therapy 
(P=0.018) & frequency of blood transfusions (P=0.030). On the 
other hand, there is no significant relationship between ROP and 
sex, mode of delivery,  birth weight, RDS, PDA, IVH, duration of 
oxygen therapy, mechanical ventilation and CPAP. 
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7. Swarna Rekha et-al12 conducted a study named “Retinopathy of 
Prematurity: Incidence and risk factors” in the Departments of 
Pediatrics and Ophthalmology, St.John’s Medical College 
Hospital, Bangalore. They screened about 100 newborn babies with 
birth weight <1500gm and/or gestational age ≤ 34 weeks and found 
out 21 babies  had stage I ROP, 14 had stage II, 8 had stage III, and 
3 had Stages IV and V. The incidence of ROP was found to be 
46%. The incidence ROP among <1000 gm babies was found to be 
73.3 and 47.3% among <1500g babies. 
The incidence of ROP among 28-29 weeks of gestational age group 
was 83% and among 30-31 weeks gestational age group was 60%, 
and among 32-33 weeks group was 50%. The significant risk 
factors associated with development of ROP were anemia, apnea, 
blood transfusions, exposure to oxygen. Of total 46 babies, 9 
underwent cryotherapy and found to be regressed. 
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8) Mojgan – Bayat-Mokhtari et.al13, conducted a study at Islamic 
Azad University, Mashhad, IR, Iran named “Incidence and Risk 
factors of  ROP among preterm infants in shiraz/Iran”. They 
included screening of preterm babies with birth weight under 
1500gm, and clinically unstable preterm babies with birth weight 
of 1500 – 2000 gm. The results showed that out of 199 preterm, 84 
babies had ROP. Incidence of ROP was 42.2%. 19 preterm babies 
out of 199, required laser photo coagulation (9.5%). Spontaneous 
regression of ROP was found in 65 infants (32.6%). The significant 
risk factors were gestational age, birth weight, Apgar score at one 
minute, mean duration of mechanical ventilation, mean duration of 
oxygen therapy, hypoxia, hyperoxia, PaCo2 > 60mmHg, pH > 7.45 
and frequent blood transfusions.  
  
17 
 
9)  A.A. Binkhathlan et.al
14 
: conducted a study at King Fahad Medical 
city, Riyadh, Saudi Arabia named “Retinopathy of prematurity in 
Saudi Arabia incidence, risk factors and the applicability of current 
screening criteria”. They screened infants born at < 36 weeks of 
gestation, and weighing 2000g at birth. The results showed that out 
of 174 infants, ROP was found to be in 93 infants (56%) ; 15% of 
those infants with ROP were in stage 3. The most significant risk 
factor for the development of ROP was gestational age at birth. The 
mean gestational age was found to be 30 weeks for the ROP 
positive group. 
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10)  Mostafa Feghhi et.al
15
 conducted a study in the south western 
region of Iran named “ Incidence of ROP and Risk factors in the 
south-western region of Iran”. They screened all the infants with 
birth weight ≤ 2000g, and with gestational age < 32 weeks who 
were admitted in the NICU’s. The results showed that out of 576 
total infants, 183 developed ROP. The majority of infants with 
ROP were in stage I or II (74.8%).Only 25.1% of infants had ROP 
of stage III or more. The significant risk factors were found to be 
lesser gestational age, lower birth weight, sepsis, duration of 
oxygen administration. The other factors like jaundice, 
phototherapy, sex and blood transfusion were not found to be 
significant.   
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STUDY JUSTIFICATION 
As already cited, more & more VLBW and ELBW babies are 
surviving today and no good epidemiological data on ROP in India is 
available. Moreover ROP is a preventable cause of blindness and vision 
related morbidity. The incidence of ROP in various studies in India varies 
from as low as 20% to as high as 60.1%. 
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AIM OF THE STUDY 
1. To find out the incidence, risk factors and outcome of newborn 
babies with Retinopathy of Prematurity in a tertiary care centre. 
2. To find out the effectiveness of laser photocoagulation among 
the Newborn babies with Retinopathy of Prematurity. 
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                OBJECTIVES OF THE STUDY 
1. To study the clinical profile of ROP in new born babies with 
ROP in an extramural centre. 
2. To find out the outcome of ROP following laser therapy. 
3. To follow up the newborn babies with ROP after screening for 
the final outcome. 
 
 
 
  
 
 
 
 
 
 
MATERIALS  AND     
METHODS
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MATERIALS AND METHODS 
1. Methodology 
a.  Study place 
(i) Department of Neonatology, 
Institute of child Health & Hospital for children, 
Egmore, 
Madras Medical College, 
Chennai. 
(ii) Retina Clinic 
Regional Institute of Ophthalmology and Government ophthalmic 
Hospital,  
Egmore,  
Madras Medical College, 
Chennai. 
b. Study design: 
 Descriptive study 
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c. Study period 
 March 2012 – November 2012 
d. Subjects: 
 Inclusion Criteria 
 All preterm babies admitted to newborn wards with birth weight 
<1500 g and gestational age <34 weeks. 
Exclusion Criteria: 
Preterm babies having congenital retinal detachment 
e. Sample size 
 Approximately 200 
2. Manoeuvre 
 All the newborn babies admitted in the newborn wards with 
birthweight <1500g and gestational age <34 weeks were enrolled on the 
basis of inclusion criteria and after obtaining written informed consent 
from the parents. Ethical clearance was obtained from the hospital ethics 
committee.  
24 
 
 Eligible preterm babies with defined criteria were registered. 
Neonatal risk factors like RDS, anaemia, apnoea, Prematurity, 
septicaemia, neonatal hyperbilirubinemia were noted. 
 Treatment details like oxygen therapy, CPAP, ventilator, use   of 
blood products, phototherapy were noted. Using + 20 D Ophthalmoscope 
all the preterm babies were screened for ROP. Some of the babies with 
severe ROP were treated with laser photo coagulation. Others were 
followed up regularly for every 2 weeks. The babies who were treated 
with laser photocoagulation were also followed up regularly for every 2 
weeks or weekly, if required. 
Screening methods: 
 The screening was done with a binocular direct ophthalmoscope. 
Eyes were examined using topical anaesthetic drops after applying topical 
tropicamide drops till full dilatation occurred. Retinopathy was graded 
into Stages and Zone as per the ICROP classification. Infants with normal 
vascularisation upto retinal periphery are not examined again. Those with 
ROP examined every two weeks till regression. Infants with Stage III 
ROP with plus disease are considered threshold for laser treatment 
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Laser treatment. 
 Laser photo coagulation was done for infants with severe ROP 
using 810nm red laser with laser indirect ophthalmoscope as early as 
possible, at least within 5 days of diagnosis of threshold disease. 
Avascular retina beyond the ridge was ablated by confluent medium 
intensity burns over one session. Topical treatment with tobraymycin and 
steroids was given for 3 days after the procedure. If skip areas were seen 
on subsequent examination, laser was repeated after one or two weeks 
according to the situation. 
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FOLLOW UP: 
Stages Zone I Zone II 
Posterior 
Zone II 
anterior 
Zone III 
Immature One Week Every Week 2 Weeks 2 Weeks 
1 ” ” 2 Weeks ” 
1+ ” ” Weekly ” 
2 ” ” ” ” 
2+ ” ” ” ” 
3 ” ” ” ” 
3+ 3 days ” ” ” 
 
When to end screening:  
a. Immature: 
- No ROP 
- Vessels are short of  1 DD of nasal or temporal ora serrata 
- Immature 1,2,3 
- Regular follow up till both nasal and temporal retina is 
vascularised. 
(40-45 Weeks) 
b. Mature: 
Vessels have reached at or within 1DD of  ora serrata. 
27 
 
Statistical Analysis: 
Statistical analysis was done using SPSS 16.0 version software. 
Descriptive statistics like mean, standard deviation, variance and range 
were arrived. Various risk factors were calculated using, 
- Univariate analysis 
- Multivariate analysis 
 
  
 
 
 
 
 
RESULTS 
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RESULTS 
 Totally 202 infants were screened for ROP in our newborn wards. 
Their gestational age ranged from 26 weeks to 36 weeks. 
 Their birth weight ranged from 700 gm to 2000 gm. Out of 202 
infants screened, 73 babies developed some stages of ROP and the overall 
incidence of ROP found to be 36.1%. Incidence of ROP among ELBW 
infants was 77.7%. Totally 62, among 126 VLBW babies developed  
ROP with the incidence rate of 49.2%. 
 There was no sex predilection in the incidence of  ROP . There was 
no difference in the incidence of ROP between AGA (appropriate for 
gestational age) and SGA (small for gestational age). 
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TABLE NO.1 PERCENTAGE OF ROP IN GESTATIONAL AGE 
GROUP 
Gestational 
Age in weeks 
ROP +ve ROP –ve Total % of ROP 
+ve 
<28  3 1 4 75% 
28 – 30 21 7 28 75% 
31 – 32 39 22 61 64% 
>33 – 34 6 54 60 10% 
>34 4 45 49 8.1% 
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FIGURE : 1 PERCENTAGE OF ROP IN GESTATIONAL AGE GROUP 
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FIGURE : 2 GESTATIONAL AGE DISTRIBUTION 
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TABLE NO.2 PERCENTAGE OF ROP IN BIRTH WEIGHT 
GROUP 
Birthweight  
in kg 
ROP  
+ve 
ROP  
–ve 
Total % of ROP 
+ve 
<1  7 2 9 77.7% 
1 – 1.3 42 23 65 64.6% 
1.31-1.5 13 39 52 25% 
1.51-1.8 10 49 59 16.9% 
>1.8 1 16 17 5.8% 
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FIGURE : 3 PERCENTAGE OF ROP IN BIRTH WEIGHT GROUP 
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FIGURE : 4 BIRTH WEIGHT DISTRIBUTION 
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TABLE NO.3 SEX PREDILECTION OF ROP 
Total cases of ROP Males Females 
73 37 36 
 50.7% 49.3% 
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FIGURE : 5 SEX PREDILECTION OF ROP 
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FIGURE : 6 GENDER DISTRIBUTION OF ROP 
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FIGURE : 7 INCIDENCE OF ROP 
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TABLE NO.4 PERCENTAGE OF ROP IN VARIOUS 
STAGES 
S.No. Stage No. of Cases 
(Total 73) 
% 
1 I 33 45.2 
2 II 21 28.7 
3 III 14 19.2 
4 IV 4 5.4 
5 V 1 1.3 
 
Out of 73 infants who had ROP, 33 were in stage I, 26 infants were 
in stage II, 14 were in stage III, 4 were in stage IV, one infant found to be 
in stage V. 
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FIGURE : 8 PERCENTAGE OF CASES IN VARIOUS STAGES 
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Among  73 infants who developed ROP , 38 infants required laser 
photocoagulation out of which 36 babies showed regression of ROP . 
Other 2 infants progressed to higher stages of ROP, of which one 
developed retinal detachment.  
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FIGURE : 9  PERCENTAGE OF ROP CASES REQUIRING LASER THERAPY 
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FIGURE : 10 EFFECTIVENESS OF LASER THERAPY 
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Univariate analysis was done accounting each risk factor. The risk 
factors included are,  
1.Gestational age 
2.Birthweight 
3.Anemia 
4. Respiratory Distress Syndrome 
5.Apnea 
6.Neonatal Hyperbilinibinaemia (NNH)  
7.Oxygen therapy 
8.Continuous Positive Airway Pressure (CPAP) 
9.Ventilators  
10.Use of blood products  
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Among the risk factors lesser gestational age ( p=0.000) VLBW & 
ELBW , (P=0.000), RDS (P=0.0002) apnea (P=0.0001), NNH (P=0.008), 
02 therapy (P=0.000), and use of blood products (P=0.000) were found to 
be significant. 
 
FREQUENCY TABLE 
Group 
ROP Frequency Percent 
        Yes 73 36.1 
        No. 129 63.9 
      Total 202 100.00 
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Gestational Age 
 
Gestational age in 
weeks 
Frequency Percent 
         <28 4 2.0 
        28-30 41 20.3 
       31-32 50 24.8 
       33-34 69 34.2 
       >34 38 18.8 
     Total 202 100.0 
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Sex 
 Frequency Percent 
Male 107 53.0 
Female 95 47.0 
Total 202 100.00 
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                                                Birth Weight 
 Frequency Percent 
< 1Kg 9 4.5 
1.0-1.3 Kg 60 29.7 
1.31-1.5 Kg 53 26.2 
1.51-1.8 Kg 63 31.2 
>1.8 Kg 17 8.4 
Total 202 100.00 
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ROP_NO ROP_Yes
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ANEMIA 
 Frequency Percent 
Yes 86 42.6 
No 116 57.4 
Total 202 100.0 
 
                                                   
 
 
                                                   
 
                                                    Sepsis 
 
 Frequency Percent 
Yes 82 40.6 
No 120 59.4 
Total 202 100.0 
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RDS 
 
 Frequency Percent 
Yes 69 34.2 
No 133 65.8 
Total 202 100.0 
 
 
 
 
 
                                                    Apnea 
 Frequency Percent 
Yes 37 18.3 
No 165 81.7 
Total 202 100.0 
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NNH 
 Frequency Percent 
Yes 142 70.3 
No 60 29.7 
Total 202 100.0 
 
 
 
 
 
 
                                                  O2 Therapy 
 
 Frequency Percent 
Yes 92 45.5 
No 110 54.5 
Total 202 100.0 
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CPAP 
 
 Frequency Percent 
Yes 55 27.2 
No 147 72.8 
Total 202 100.0 
 
 
 
                                              VENTILATOR 
 
 Frequency Percent 
Yes 23 11.4 
No 179 88.6 
Total 202 100.0 
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Blood Products 
 
 Frequency Percent 
Yes 58 28.7 
No 144 71.3 
Total 202 100.0 
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ASSOCIATION OF GESTATIONAL AGE WITH ROP 
 Gestational  Age in weeks Total 
<28  28-30 31-32 33-34 >34 
Group ROP_Yes Count 
 
% within group 
3 
 
4.1% 
34 
 
46.6% 
28 
 
38.4% 
5 
 
6.8% 
3 
 
4.1% 
 
 
73 
 
100% 
 ROP No Count 
 
1 
 
.8% 
7 
 
5.4% 
22 
 
17.1% 
 
64 
 
49.6% 
35 
 
27.1% 
129 
 
100% % within Group 
Total Count 4 
 
2.0% 
 
41 
 
20.3% 
50 
 
24.8% 
69 
 
34.2% 
38 
 
18.8% 
202 
 
100%  % within Group 
 
P=0.000 
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ASSOCIATION OF SEX WITH ROP 
 Sex  
Male Female 
Group ROP_Yes Count 
 
% within group 
37 
 
50.7% 
36 
 
49.3% 
71 
 
100% 
 ROP No Count 
 
70 
 
54.3% 
50 
 
45.7% 
129 
 
100% % within Group 
Total Count 107 
 
53.0% 
 
95 
 
47.0% 
202 
 
100%  % within Group 
 
P=0.624  
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ASSOCIATION OF BIRTH WEIGHT WITH ROP 
 
 Birth Weight Total 
<1 Kg 1.0-1.3 Kg 1.31-1.5 Kg 1.51-1.8 Kg >1.8 Kg 
Group ROP_Yes Count 
 
% within group 
7 
 
9.6% 
41 
 
56.2% 
14 
 
19.2% 
10 
 
13.7% 
1 
 
1.4% 
 
73 
 
100% 
 ROP No Count 
 
2 
 
1.6% 
19 
 
14.7% 
39 
 
30.2% 
 
53 
 
41.1% 
16 
 
12.4% 
129 
 
100% % within Group 
Total Count 9 
 
4.5% 
 
60 
 
29.7% 
53 
 
26.2% 
63 
 
31.2% 
17 
 
8.4% 
202 
 
100%  % within Group 
 
P=0.000 
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ASSOCIATION OF ANAEMIA WITH ROP 
 
 Anemia Total 
Yes No 
Group ROP_Yes Count 
 
% within group 
33 
 
45.2% 
40 
 
54.8% 
73 
 
100% 
 ROP No Count 
 
53 
 
41.1% 
76 
 
58.9% 
129 
 
100% % within Group 
Total Count 86 
 
42.6% 
 
116 
 
57.4% 
202 
 
100% 
 
P=0.569 
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FIGURE : 11 ASSOCIATION OF ANEMIA WITH ROP 
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ASSOCIATION OF SEPSIS WITH ROP 
 Sepsis Total 
Yes No 
Group ROP_Yes Count 
 
% within group 
49 
 
67.1% 
24 
 
32.9% 
73 
 
100% 
 ROP No Count 
 
33 
 
25.6% 
96 
 
74.4% 
129 
 
100% % within Group 
Total Count 82 
 
40.6% 
 
120 
 
59.4% 
202 
 
100% 
P = o.ooo
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FIGURE : 12 ASSOCIATION OF SEPSIS WITH ROP 
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ASSOCIATION OF RDS WITH ROP 
 
 RDS Total 
Yes No 
Group ROP_Yes Count 
 
% within group 
35 
 
47.9% 
38 
 
52.1% 
73 
 
100% 
 ROP No Count 
 
34 
 
26.4% 
95 
 
73.6% 
129 
 
100% % within Group 
Total Count 69 
 
34.2% 
 
133 
 
65.8% 
202 
 
100% 
 
P = o.oo2 
63 
 
FIG : 13 ASSOCIATION OF RDS WITH ROP 
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ASSOCIATION OF APNEA WITH ROP 
 
 Apnea Total 
Yes No 
Group ROP_Yes Count 
 
% within group 
24 
 
32.9% 
49 
 
67.1% 
73 
 
100% 
 ROP No Count 
 
13 
 
10.1% 
116 
 
89.9% 
129 
 
100% % within Group 
Total Count 37 
 
18.3% 
 
165 
 
81.7% 
202 
 
100% 
 
P=0.000 
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Figure : 14 ASSOCIATION OF APNEA WITH ROP 
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ASSOCIAITON OF NNH WITH ROP 
 NNH Total 
Yes No 
Group ROP_Yes Count 
 
% within group 
43 
 
58.9% 
30 
 
41.1% 
73 
 
100% 
 ROP No Count 
 
99 
 
76.7% 
30 
 
23.3% 
129 
 
100% % within Group 
Total Count 142 
 
70.3 
 
60 
 
29.7 
202 
 
100% 
 
P=0.008 
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FIGURE : 15 ASSOCIATION OF NNH WITH ROP 
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ASSOCIATION OF O2 THERAPY WITH ROP 
 O2 Therapy Total 
Yes No 
Group ROP_Yes Count 
 
% within group 
46 
 
63.0% 
27 
 
37.0% 
73 
 
100% 
 ROP No Count 
 
46 
 
35.7% 
83 
 
64.3% 
129 
 
100% % within Group 
Total Count 92 
 
45.5% 
 
110 
 
54.5% 
202 
 
100% 
 
P=0.000
69 
 
FIGURE : 16 ASSOCIATION OF O2 THERAPY WITH ROP 
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ASSOCIATION OF CPAP WITH ROP 
 CPAP Total 
Yes No 
Group ROP_Yes Count 
 
% within group 
22 
 
30.1% 
51 
 
69.9% 
73 
 
100% 
 ROP No Count 
 
33 
 
25.6% 
96 
 
74.4% 
129 
 
100% % within Group 
Total Count 55 
 
27.2% 
 
147 
 
72.8% 
202 
 
100% 
 
P=0.485 
ASSOCIAITON OF VENTILATOR WITH ROP 
 
 Group Ventilator Total 
Yes No 
Group ROP_Yes Count 
 
% within group 
9 
 
12.3% 
64 
 
87.7% 
73 
 
100% 
 ROP No Count 
 
14 
 
10.9% 
115 
 
89.1% 
129 
 
100% % within Group 
Total Count 23 
 
11.4% 
 
179 
 
88.6% 
202 
 
100% 
 
P=0.751 
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ASSOCIATION OF BLOOD PRODUCTS WITH ROP 
 Blood Products Total 
Yes No 
Group ROP_Yes Count 
 
% within group 
32 
 
43.8% 
41 
 
56.2% 
73 
 
100% 
 ROP No Count 
 
26 
 
20.2% 
103 
 
79.8% 
129 
 
100% % within Group 
Total Count 58 
 
28.7% 
 
144 
 
71.3% 
202 
 
100% 
P=0.000 
FIGURE : 17 ASSOCIATION OF BLOOD PRODUCTS WITH RO 
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DISCUSSION  
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DISCUSSION 
 We screened all the babies admitted in our newborn wards with 
birth weight <1500gm and/or gestational age <34 weeks. The study 
conducted by Swarna Rekha et al
12 
 also had same screening criteria 
which showed an  incidence of ROP as 46%. In our study the incidence 
was 36.1%. The incidence of ROP in various studies in India varies from 
20% to 60.2%. 
 The incidence of ROP in the west had been reported as 53% - 
88.5% in <1000g babies. In our study it was 77.7% which was 
comparable to the previous studies. The incidence of ROP in <1500g 
babies was found to be 34.9-60.1% in western studies. In our study we 
found the incidence was about 49.2% which seems to follow a similar 
pattern. 
Incidence of ROP has been reported as 82.5%  in  babies <28 
weeks and in our study it was 75% which is somewhat lower than the 
previous studies. The incidence of ROP in  28 – 30 weeks group found to 
be 27% in the previous study. But in our study the incidence seems to be 
higher  than the previous one (64%). 
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There were varying screening criteria described by different 
authors for ROP screening.  Maheswari et al
10
 screened the babies with 
birth weight 1500g and / or gestational 35 week. Vinekar et al16 
suggested that larger birth weight and gestationally  older infants in India 
were more likely to develop ROP compared to their counterparts in 
western countries. Jalat et al (14) suggested that infants with  birth weight 
<2000g gestational age <37 weeks should also be screened.  
Many risk factors were found to be predisposing to the 
development of ROP. Of which oxygen therapy, anemia, use of blood 
products, septicemia, apnea and RDS were important risk factors.  In our 
study lower birth weight, lesser gestational age, apnea, RDS, oxygen 
therapy, sepsis, use of blood products, neonatal hyperbilirubinemia were 
found to be significant risk factors. Vinekar et al
13, 
found that septicemia 
was a significant risk factor. Aggarwal et al
10
 found that apnea, clinical 
sepsis and male sex were significant risk factors. 
Ng et al
18
,and Connolly, et al
19 
have found that long term structural 
and functional outcome using laser photocoagulation yielded favorable 
results. Laser therapy does not need the use of general anaesthesia and 
has milder complications. 
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 In our study, 38 infants with ROP required laser photocoagulation.  
Of which 36 infants (94.7%) had regression of ROP after laser photo 
coagulation which showed good results with laser therapy. 
        As ROP is essentially asymptomatic in earlier stages, 
carefully timed retinal examination of at risk infants for ROP by an 
ophthalmologist experienced in retinal examination in  infants is required 
to minimize the risk of loss of vision in these infants. 
 
 
  
 
 
 
SUMMARY 
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SUMMARY 
ROP is a preventable cause of blindness and vision related 
morbidity. As there are improvement in neonatal health care facilities and 
Neonatal Intensive Care Units, the survival of more and more VLBW & 
ELBW babies are increasing who are at risk for developing ROP. So the 
incidence of ROP is in increasing trend  all over the world. More over no 
good epidemiological data on ROP in Tamil Nadu is available. 
 Hence we conducted a prospective study to determine the 
incidence, risk factors, clinical  outcome of laser therapy among the 
newborn babies with birth weight <1500gm, and /or gestational <34 
weeks admitted in our newborn wards. Total of 202 newborns were 
included in this study, among them 73 developed ROP. The overall 
incidence of ROP was found to be 36.1%. We also found that lesser 
gestational age, lower birth weight, RDS, apnea, NNH, oxygen therapy, 
use of blood products were found to be significant risk factors. Efficacy 
of laser photo coagulation was 94.7%. 36 out of 38 infants treated with 
laser showed regression ROP. 
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 In our study we found that the following risk factors are 
significantly associated with the development of ROP. 
1. Gestational age  
2. Birth weight . 
3. RDS  
4. Apnea 
5. NNH 
6. O2 Therapy 
7. Use of Blood Products 
 
 
 
  
 
 
 
LIMITATIONS OF THE 
STUDY 
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LIMITATIONS OF THE STUDY:  
In our study, the screening population were obtained from an 
extramural centre only. The intramural sample and sample were not 
included.  So the comparison between intramural and extramural 
population could not be obtained.  
Since the oxygen blender was not available, the fio2   
concentrations at which level, the maximum risk for development of ROP 
could not be obtained.  
As the arterial blood gas analysis was not available consistently, 
the association of acidosis with ROP as a risk factor could not be 
identified. 
  
 
 
 
 
CONCLUSION 
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CONCLUSION 
In our study, we conclude that the incidence of  ROP was 36.1% .  
The risk factors for the development of ROP were also similar to those 
mentioned in earlier studies like prematurity, oxygenation, sepsis, 
respiratory distress. Proper screening  of at risk babies found to be cost 
effective in preventing from the development of ROP. 
 We recommed that intial assessment for screening of ROP  to be 
done as early as at least 4 weeks post natal age or 34-35 weeks 
postconceptional age and these  babies are to be followed till term 
gestation. 
 Laser photocoagulation found to be a safer  therapeutic procedure 
with good outcome and milder complications.  
          Larger birth weight babies and gestationally  more older babies 
may also develop ROP. So, the criteria for ROP screening should be 
extended to the larger birth weight babies upto 1.8 kg and older 
gestational age babies upto 36 weeks especially those with risk factors 
like  sepsis, apnea, RDS and those who need blood transfusion.  
          It seems that prevention of premature and deliveries and judicious 
use of oxygen are found to be the main step for prophylaxis of ROP. 
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ANNEXURE 
  
  
 
PROFORMA FOR THE STUDY 
 
NAME:      AGE:   SEX: 
DATE OF EXAMINATION: 
ROLL NO: 
BIRTH WEIGHT: 
GESTATIONAL AGE: 
POST CONCEPTIONAL AGE: 
ADDRESS: 
 
 
TELEPHONE NO: 
FATHER’S NAME: 
MOTHER’S NAME: 
 
NEO-NATAL RISK FACTORS 
ANEMIA: 
SEPSIS 
RDS: 
APNEA OF PREMATURITY: 
HYPERBILIRUBINEMIA: 
  
TREATMENT DETAILS 
 
OXYGEN THERAPY: 
CPAP: 
VENTILATOR THERAPY: 
BLOOD COMPONENTS: 
PHOTOTHERAPY: 
 
  
  
ABBREVIATION 
 
AGA =  appropriate for gestational age 
CPAP  =  continuous positive airway pressure 
ELBW =  extremely low birth weight 
ICROP =  international classification of retinopathy of          
  prematurity 
NNH  =  neonatal hyperbilirubinaemia 
O2   = oxygen 
RDS  = respiratory distress syndrome 
ROP  =  retinopathy of prematurity 
SGA  = small for gestational age 
VEGF = vascular endothelial growth factor 
VLBW = very low birth weight 
 
  
s.no gest.age sex birthwt anemia sepsis resp.dist. apnea NNH O2therapy CPAP ventilator bloodproducts 
1 3 1 2 2 1 2 2 1 2 2 2 2 
2 3 2 2 2 2 2 2 2 2 2 2 2 
3 3 2 2 1 1 2 2 1 1 1 2 1 
4 3 1 2 1 2 1 2 1 1 1 2 2 
5 3 2 2 2 1 1 2 1 1 2 2 1 
6 3 2 3 2 2 2 2 1 2 2 2 2 
7 4 2 3 1 2 2 2 1 2 2 2 1 
8 3 1 4 1 1 2 1 1 1 2 2 1 
9 4 1 2 2 2 2 2 1 2 2 2 2 
10 2 2 4 2 2 2 2 1 2 2 2 2 
11 2 1 2 1 1 1 2 1 1 2 2 2 
12 2 1 2 2 2 1 2 1 1 1 2 2 
13 2 2 2 2 2 2 2 2 2 2 2 2 
14 2 1 2 2 2 2 2 2 2 2 2 2 
15 4 1 2 2 2 2 2 2 2 2 2 2 
16 2 1 2 2 1 1 2 1 1 2 2 2 
17 2 2 3 2 1 2 1 1 1 2 2 1 
18 3 1 2 1 1 1 2 1 1 1 2 1 
19 4 2 2 1 1 2 1 1 2 2 2 2 
20 2 2 2 2 1 1 2 1 1 1 2 1 
21 2 2 2 1 1 1 1 1 1 1 1 1 
22 3 1 3 2 1 2 1 2 1 2 2 2 
23 2 2 2 1 2 2 2 2 2 2 2 2 
24 2 1 2 2 2 1 2 1 1 1 2 2 
25 2 2 2 2 1 2 1 1 2 2 2 1 
MASTER CHART 
  
26 1 1 1 2 1 2 2 1 2 2 2 1 
27 2 1 2 1 1 1 2 1 1 2 2 1 
28 3 2 2 1 2 2 2 2 2 2 2 2 
29 5 2 4 2 1 2 2 1 1 2 2 2 
30 1 2 1 1 1 1 1 1 1 1 1 1 
31 2 1 2 1 1 1 2 1 1 1 2 1 
32 5 1 4 2 1 2 2 1 2 2 2 1 
33 2 1 3 2 2 1 2 2 1 2 2 2 
34 5 1 3 2 2 2 2 1 2 2 2 2 
35 2 2 1 2 1 1 1 1 1 1 2 2 
36 2 2 1 2 2 1 1 1 1 1 1 1 
37 2 1 2 2 1 2 2 2 2 2 2 2 
38 2 1 2 1 1 1 2 1 1 2 2 1 
39 2 1 2 1 1 1 1 2 1 1 2 2 
40 2 2 1 1 1 1 1 1 1 2 1 1 
41 3 1 3 1 1 2 1 2 1 2 2 1 
42 3 2 3 2 2 2 2 1 2 2 2 2 
43 3 2 2 2 1 2 2 2 2 2 2 2 
44 3 1 3 2 1 2 2 2 2 2 2 2 
45 2 1 1 1 1 1 1 1 1 2 1 1 
46 2 2 2 2 1 2 2 2 1 2 2 2 
47 3 2 5 2 2 2 2 2 2 2 2 2 
48 3 1 2 1 1 2 1 2 1 2 2 1 
49 2 1 2 1 2 1 1 1 1 1 2 2 
50 4 1 4 2 1 1 2 2 1 2 2 2 
51 3 2 4 1 1 1 2 2 1 1 2 1 
  
52 2 2 4 1 1 1 2 2 1 1 2 1 
53 2 2 2 2 1 1 1 1 1 1 2 2 
54 3 1 3 2 2 2 2 2 2 2 2 2 
55 2 1 2 1 1 2 1 1 1 2 2 1 
56 2 2 2 1 1 1 1 2 1 1 2 1 
57 3 2 1 1 1 1 1 1 1 2 1 1 
58 2 1 2 2 2 1 2 2 1 2 2 2 
59 3 1 3 1 2 2 2 2 2 2 2 2 
60 2 1 2 2 1 1 2 1 1 2 2 2 
61 3 1 2 1 1 1 2 2 1 2 2 2 
62 1 2 3 1 1 2 1 1 1 1 2 2 
63 3 2 4 2 1 2 2 1 2 2 2 2 
64 2 2 4 2 1 2 2 2 2 2 2 2 
65 3 2 2 1 1 2 1 1 1 1 2 1 
66 3 2 2 1 1 1 2 1 1 1 2 1 
67 3 1 2 2 1 1 1 2 1 1 1 1 
68 2 1 3 1 1 2 2 2 2 2 2 1 
69 3 2 2 1 1 1 1 1 1 2 1 1 
70 3 2 2 2 1 1 2 2 1 1 2 1 
71 2 2 4 2 2 2 2 1 2 2 2 2 
72 2 1 2 1 1 1 1 2 1 2 1 1 
73 3 1 3 2 2 1 2 2 1 2 2 2 
 
